Senior Regulatory Affairs Executive
4 Years of Experience Medical device regulatory professional specializing in EU MDR 2017/745
Medical device cybersecurity is essential for protecting patients, safeguarding health information, and meeting regulatory requirements across global markets. Operon Strategist supports medical device and in vitro diagnostic (IVD) manufacturers with regulatory strategy, quality management, technical documentation, and compliance planning to help prepare products for market entry.
As medical devices become increasingly connected through hospital networks, wireless interfaces, cloud platforms, and software applications, cybersecurity risks can directly affect device safety and performance. Manufacturers must therefore consider cybersecurity from product design and development through regulatory submission, commercialization, and postmarket monitoring.
This guide explains medical device cybersecurity, key regulatory expectations, essential security controls, documentation requirements, and practical steps manufacturers can take to strengthen compliance.
What Is Medical Device Cybersecurity?
Medical device cybersecurity is the set of technical, organizational, and lifecycle measures used to protect medical devices, their software, connected systems, and associated data against unauthorized access, modification, disruption, or exploitation.
It applies to devices that use software, firmware, wireless connectivity, network interfaces, cloud services, or other digital technologies. The specific cybersecurity measures required depend on the device’s intended use, architecture, connectivity, foreseeable threats, and potential consequences of a security incident.
Examples of devices and systems with cybersecurity considerations include:
- Patient monitors and connected bedside equipment
- Infusion pumps and other network-connected therapeutic devices
- Medical imaging systems
- In vitro diagnostic analyzers and connected laboratory instruments
- Software as a Medical Device (SaMD)
- Remote patient monitoring systems
- Devices that exchange data with hospital information systems or cloud platforms
A device does not need to connect directly to the internet to have cybersecurity risks. Local networks, maintenance interfaces, removable media, software dependencies, and connections to other systems may also create vulnerabilities.
Why Is Cybersecurity Important for Medical Devices and IVDs?
Medical device cybersecurity is important because a security weakness can affect patient safety, device availability, data integrity, and regulatory compliance.
1. Protecting Patient Safety
A cyberattack could disrupt device operation, alter data, prevent access to essential functions, or interfere with clinical workflows. For example, inaccurate laboratory results or interrupted patient monitoring could influence clinical decisions.
Manufacturers should assess cybersecurity risks according to their potential effect on device safety and performance, rather than treating every vulnerability as an equivalent technical issue.
2. Protecting Health Information
Connected medical devices may collect, process, store, or transmit sensitive patient information. Appropriate access controls, encryption where suitable, secure data handling, and authentication measures can help protect confidentiality and integrity.
Privacy obligations depend on the markets and organizations involved. For example, GDPR may apply to personal data processing in the European Union, while HIPAA requirements apply to covered entities and business associates within their scope in the United States.
3. Meeting Regulatory Expectations
Regulators increasingly expect manufacturers to demonstrate that cybersecurity has been considered throughout the product lifecycle.
In the United States, FDA recommendations address secure device design, cybersecurity risk management, premarket documentation, and postmarket vulnerability handling. In Europe, applicable cybersecurity considerations must be addressed within the safety, performance, risk management, and software requirements of MDR and IVDR.
4. Reducing Commercial and Operational Risk
Cybersecurity incidents can lead to product updates, investigations, customer notifications, service interruptions, field safety actions, and reputational damage.
A planned cybersecurity program helps manufacturers identify and address weaknesses before they become costly operational or patient safety issues.
What Are the Main Medical Device Cybersecurity Regulatory Requirements?
Medical device cybersecurity requirements vary by jurisdiction, device type, regulatory pathway, and product risk. Manufacturers selling internationally should identify the requirements that apply to each target market.
US FDA Cybersecurity Requirements
The FDA’s Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions guidance, issued in February 2026, provides recommendations on secure device design, labeling, and documentation for premarket submissions involving cybersecurity risk. It supersedes the June 2025 version and reflects updates aligned with the FDA’s QMSR.
Section 524B of the Federal Food, Drug, and Cosmetic Act also establishes requirements for manufacturers submitting applications for devices that meet the statutory definition of a cyber device.
These requirements include:
- Providing a plan to monitor, identify, and address postmarket cybersecurity vulnerabilities and exploits.
- Designing, developing, and maintaining processes and procedures that provide reasonable assurance of cybersecurity.
- Making available postmarket updates and patches to address vulnerabilities.
- Providing a software bill of materials (SBOM) covering applicable software components, including commercial, open-source, and off-the-shelf components.
The applicable obligations should be assessed against the statutory definition of a cyber device and the relevant submission requirements.
EU MDR and IVDR Cybersecurity Considerations
The European Medical Device Regulation (EU MDR 2017/745) and In Vitro Diagnostic Medical Device Regulation (EU IVDR 2017/746) establish safety and performance requirements that can include cybersecurity considerations for software-enabled and connected devices.
Manufacturers should consider cybersecurity within relevant areas such as:
- Risk management and foreseeable risks
- Software design and verification
- Protection against unauthorized access and data corruption
- Safety and performance of connected functions
- Information supplied to users and operators
- Postmarket surveillance and corrective action
The precise documentation and evidence required depend on the device, its intended purpose, applicable essential requirements, and conformity assessment route. Cybersecurity should be integrated into the overall technical documentation rather than treated as an isolated report.
Other International Markets
Manufacturers entering additional markets should assess local regulatory requirements and relevant guidance from the competent authority.
Depending on the product and jurisdiction, relevant considerations may include software lifecycle processes, risk management, information security, privacy, incident reporting, and postmarket monitoring.
A single cybersecurity evidence package may support several markets, but it should be mapped to the specific requirements of each applicable regulatory framework.
How Should Manufacturers Implement Medical Device Cybersecurity?
An effective cybersecurity program starts during product planning and continues throughout the device lifecycle.
Step 1: Define the Device’s Cybersecurity Scope
Identify the device’s software, firmware, hardware interfaces, network connections, external services, users, and data flows.
Document how the device interacts with hospital networks, mobile applications, cloud systems, laboratory infrastructure, and other connected products.
This information helps establish the cybersecurity scope and identify the systems that could affect device safety or performance.
Step 2: Conduct Cybersecurity Risk Assessment
Identify potential threats, vulnerabilities, attack paths, and the consequences of successful exploitation.
Consider risks such as unauthorized access, data manipulation, service interruption, malicious software, compromised software dependencies, and insecure configuration.
Assess the potential impact on:
- Patient safety
- Device functionality and availability
- Data confidentiality and integrity
- Clinical and laboratory workflows
- Regulatory compliance
Cybersecurity risk assessment should be connected to the manufacturer’s broader risk management process. Risk controls must be selected, implemented, verified, and reviewed for effectiveness.
Step 3: Apply Secure Design Principles
Cybersecurity should be incorporated into design inputs and product architecture rather than added only before submission.
Depending on the device, controls may include:
- Strong authentication and role-based access
- Least-privilege permissions
- Secure configuration and system hardening
- Encryption and secure communication protocols
- Protection against unauthorized software changes
- Secure boot and integrity checks where appropriate
- Logging, monitoring, and security event handling
- Controlled software updates and recovery mechanisms
Controls should be proportionate to the device’s intended use, architecture, threats, and risk profile.
Step 4: Verify and Validate Security Controls
Manufacturers should establish evidence that cybersecurity requirements have been implemented and that security risks have been appropriately addressed.
Testing may include:
- Vulnerability scanning
- Penetration testing
- Static and dynamic application security testing
- Fuzz testing
- Authentication and authorization testing
- Software composition analysis
- Interface and communication security testing
- Review of security-related design requirements
Not every test applies to every device. The test strategy should be risk-based and appropriate to the product’s architecture and intended use.
Document the test methods, scope, findings, corrective actions, and results. Unresolved findings should be evaluated to determine whether they create unacceptable residual risks.
Step 5: Prepare Cybersecurity Documentation
Organize cybersecurity evidence so that reviewers can understand the device’s architecture, identified risks, security controls, testing results, and plans for ongoing maintenance.
Documentation should be consistent with the device’s intended use, labeling, software documentation, risk management records, and applicable submission requirements.
Step 6: Establish Postmarket Cybersecurity Management
Cybersecurity risks may change after commercialization as new vulnerabilities are discovered, software dependencies change, and threat methods evolve.
Manufacturers should establish processes to:
- Monitor security advisories and vulnerability reports.
- Assess the impact of new vulnerabilities on their devices.
- Prioritize risks based on severity and potential patient impact.
- Develop, test, and distribute appropriate patches or updates.
- Communicate security information to relevant users and customers.
- Maintain records of investigations, decisions, and corrective actions.
A defined postmarket process helps manufacturers respond to security issues while maintaining device safety and regulatory compliance.
What Cybersecurity Documents Should Medical Device Manufacturers Prepare?
The documentation required depends on the product, regulatory pathway, applicable law, and submission type. A cybersecurity documentation package may include the following:
| Document or Evidence | Purpose |
|---|---|
| Device architecture and data-flow diagrams | Identify components, interfaces, and data exchanges |
| Threat model | Describe potential threats and attack paths |
| Cybersecurity risk assessment | Evaluate security risks and planned controls |
| Security requirements and design specifications | Define the intended security measures |
| Software Bill of Materials (SBOM) | Identify software components and dependencies |
| Security verification and validation reports | Demonstrate that relevant controls were tested |
| Vulnerability assessment and penetration test reports | Evaluate weaknesses and potential exploitability |
| Cybersecurity labeling and user instructions | Explain relevant security configuration and use |
| Vulnerability monitoring and response plan | Define how emerging risks will be handled |
| Patch and update management procedures | Support controlled remediation of vulnerabilities |
| Cybersecurity incident response procedures | Establish investigation, escalation, and communication processes |
This list is a planning aid, not a universal mandatory document list. Manufacturers should map each item to the relevant FDA submission recommendations, statutory obligations, or applicable EU requirements.
How Does a Quality Management System Support Medical Device Cybersecurity?
A Quality Management System provides the processes needed to plan, document, review, and maintain cybersecurity activities across the device lifecycle.
For US manufacturers, the FDA’s QMSR became effective on February 2, 2026, aligning the framework more closely with ISO 13485:2016 through incorporation by reference.
Cybersecurity-related activities may be incorporated into relevant QMS processes, including:
- Design and development controls
- Risk management
- Supplier and software component controls
- Verification and validation
- Configuration and change management
- Complaint handling and incident investigation
- Corrective and preventive action
- Postmarket monitoring
ISO 13485 certification alone does not establish that a device is cybersecure. Manufacturers must still address the applicable device-specific cybersecurity risks and regulatory expectations.
How Operon Strategist Can Help With Medical Device Cybersecurity
Operon Strategist supports medical device manufacturers and IVD companies with regulatory planning and quality system activities that contribute to cybersecurity readiness.
Support can be aligned with the product’s development stage, target markets, and regulatory pathway.
Regulatory Requirements and Gap Assessment
Identify relevant cybersecurity requirements and assess existing documentation against applicable FDA and international regulatory expectations.
FDA Submission Readiness
Support the organization and review of cybersecurity-related technical documentation for applicable FDA submissions, including relevant FDA 510(k) preparation activities.
Quality Management System Support
Help integrate cybersecurity-related processes into design controls, risk management, supplier controls, change management, and postmarket procedures.
Technical Documentation Coordination
Help manufacturers organize device information, risk records, verification evidence, software documentation, and supporting regulatory records.
Product Development and Manufacturing Planning
For companies developing new medical devices or establishing manufacturing operations, regulatory planning can be coordinated with product feasibility, process engineering, and Quality Management System requirements.
The specific scope depends on the product and project requirements. Cybersecurity testing and specialized technical assessments should be performed by appropriately qualified professionals where needed.
Planning a medical device launch or preparing a regulatory submission? Contact Operon Strategist to discuss regulatory documentation, QMS readiness, and the support required for the intended market.
Senior Regulatory Affairs Executive | 4 Years of Experience
Medical device regulatory professional specializing in EU MDR 2017/745 technical documentation, CE marking, risk management, clinical and biological evaluation, and post-market surveillance. His expertise includes SFDA MDMA submissions, CDSCO licensing, ISO 13485, MDSAP, US FDA regulatory requirements, and BIS certification.
